Tanja Langsenlehner

1.6k total citations
56 papers, 1.2k citations indexed

About

Tanja Langsenlehner is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tanja Langsenlehner has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tanja Langsenlehner's work include Inflammatory Biomarkers in Disease Prognosis (15 papers), Cancer, Lipids, and Metabolism (8 papers) and Angiogenesis and VEGF in Cancer (7 papers). Tanja Langsenlehner is often cited by papers focused on Inflammatory Biomarkers in Disease Prognosis (15 papers), Cancer, Lipids, and Metabolism (8 papers) and Angiogenesis and VEGF in Cancer (7 papers). Tanja Langsenlehner collaborates with scholars based in Austria, Germany and United States. Tanja Langsenlehner's co-authors include Uwe Langsenlehner, Armin Gerger, Karin S. Kapp, Sabine Krenn-Pilko, Wilfried Renner, Tatjana Stojaković, Martin Pichler, Max Pichler, Peter Krippl and Günter Hofmann and has published in prestigious journals such as PLoS ONE, Scientific Reports and British Journal of Cancer.

In The Last Decade

Tanja Langsenlehner

54 papers receiving 1.2k citations

Peers

Tanja Langsenlehner

ONCOL

PRM

SURGE

Antonio Febbraro Italy

Liyi Xie China

Jay P. Reddy United States

Jindřich Fínek Czechia

Isabelle Peyrottes France

Uwe Langsenlehner Austria

Soichiro Funaki Japan

Mauro Loi Italy

Antonio Febbraro Italy

Tanja Langsenlehner

649 ×1.1

ONCOL

241 ×0.7

249 ×0.8

314 ×1.0

PRM

253 ×1.5

SURGE

Citations per year, relative to Tanja Langsenlehner Tanja Langsenlehner (= 1×) peers Antonio Febbraro

Countries citing papers authored by Tanja Langsenlehner

Since Specialization

Citations

This map shows the geographic impact of Tanja Langsenlehner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tanja Langsenlehner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tanja Langsenlehner more than expected).

Fields of papers citing papers by Tanja Langsenlehner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tanja Langsenlehner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tanja Langsenlehner. The network helps show where Tanja Langsenlehner may publish in the future.

Co-authorship network of co-authors of Tanja Langsenlehner

This figure shows the co-authorship network connecting the top 25 collaborators of Tanja Langsenlehner. A scholar is included among the top collaborators of Tanja Langsenlehner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tanja Langsenlehner. Tanja Langsenlehner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Niedrist, Tobias, et al.. (2024). Radiotherapy and inflammaging: the influence of prostate cancer radiotherapy on systemic inflammation. World Journal of Urology. 43(1). 35–35.

Kleber, Marcus E., Brigitte M. Winklhofer‐Roob, Wilfried Renner, et al.. (2024). Haptoglobin polymorphism, vitamin E and mortality: the Ludwigshafen Risk and Cardiovascular Health Study. BMJ Nutrition Prevention & Health. 7(2). 296–303.

Magyar, Marton, et al.. (2020). Clinical parameters predictive for sphincter-preserving surgery and prognostic outcome in patients with locally advanced low rectal cancer. Radiation Oncology. 15(1). 99–99. 6 indexed citations

Reinisch, Sabine, et al.. (2020). The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy. Radiation Oncology. 15(1). 259–259. 8 indexed citations

Kaiser, Melanie, et al.. (2020). Haptoglobin polymorphism and prostate cancer mortality. Scientific Reports. 10(1). 13117–13117. 8 indexed citations

Renner, Wilfried, Sabine Krenn-Pilko, Hans‐Jürgen Gruber, Markus Herrmann, & Tanja Langsenlehner. (2018). Relative telomere length and prostate cancer mortality. Prostate Cancer and Prostatic Diseases. 21(4). 579–583. 18 indexed citations

Langsenlehner, Tanja, Sabine Krenn-Pilko, Uwe Langsenlehner, et al.. (2015). Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients. World Journal of Urology. 33(11). 1661–1667. 43 indexed citations

Krenn-Pilko, Sabine, Uwe Langsenlehner, Tatjana Stojaković, et al.. (2015). The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients. Tumor Biology. 37(1). 361–368. 39 indexed citations

Langsenlehner, Uwe, Günter Hofmann, Wilfried Renner, et al.. (2014). Association of vascular endothelial growth factor – A gene polymorphisms and haplotypes with breast cancer metastases. Acta Oncologica. 54(3). 368–376. 14 indexed citations

10.

Langsenlehner, Tanja, et al.. (2014). Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy. Strahlentherapie und Onkologie. 190(4). 364–369. 11 indexed citations

11.

Absenger, Gudrun, Joanna Szkandera, Michael Stotz, et al.. (2013). A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early‐stage breast cancer. Molecular Carcinogenesis. 52(S1). 96–102. 12 indexed citations

12.

Szkandera, Joanna, Thomas Winder, Michael Stotz, et al.. (2013). A common gene variant in PLS3 predicts colon cancer recurrence in women. Tumor Biology. 34(4). 2183–2188. 11 indexed citations

13.

Langsenlehner, Tanja, Wilfried Renner, Armin Gerger, et al.. (2011). Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients. Strahlentherapie und Onkologie. 187(12). 784–791. 15 indexed citations

14.

Gerger, Armin, Wilfried Renner, Tanja Langsenlehner, et al.. (2009). Association of interleukin-10 gene variation with breast cancer prognosis. Breast Cancer Research and Treatment. 119(3). 701–705. 39 indexed citations

15.

Stranzl, Heidi, et al.. (2009). Wide Tangential Fields Including the Internal Mammary Lymph Nodes in Patients with Left-Sided Breast Cancer. Strahlentherapie und Onkologie. 185(3). 155–160. 43 indexed citations

16.

Hofmann, G, Uwe Langsenlehner, Tanja Langsenlehner, et al.. (2009). A common hereditary single‐nucleotide polymorphism in the gene of FAS and colorectal cancer survival. Journal of Cellular and Molecular Medicine. 13(9b). 3699–3702. 3 indexed citations

17.

Langsenlehner, Tanja, Ramona Mayer, Franz Quehenberger, et al.. (2008). The Role of Radiation Therapy after Incomplete Resection of Penile Cancer. Strahlentherapie und Onkologie. 184(7). 359–363. 12 indexed citations

18.

Clar, H.-E., Uwe Langsenlehner, Peter Krippl, et al.. (2007). A polymorphism in the G protein β3-subunit gene is associated with bone metastasis risk in breast cancer patients. Breast Cancer Research and Treatment. 111(3). 449–452. 14 indexed citations

19.

Langsenlehner, Uwe, Gerald Wolf, Tanja Langsenlehner, et al.. (2007). Genetic polymorphisms in the vascular endothelial growth factor gene and breast cancer risk. The Austrian “tumor of breast tissue: incidence, genetics, and environmental risk factors” study. Breast Cancer Research and Treatment. 109(2). 297–304. 39 indexed citations

20.

Langsenlehner, Tanja, Uwe Langsenlehner, Wilfried Renner, et al.. (2007). The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases. The Prostate. 68(3). 264–268. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact